Phio Pharmaceuticals Corp (44R3)

1.798
-0.014(-0.77%)
  • Volume:
    600
  • Bid/Ask:
    1.798/1.868
  • Day's Range:
    1.798 - 1.798
  • Type:Equity
  • Market:Germany
  • ISIN:US71880W3034
  • WKN:A2PYB0

44R3 Overview

Prev. Close
1.812
Day's Range
1.798-1.798
Revenue
-
Open
1.798
52 wk Range
1.356-3.72
EPS
-
Volume
600
Market Cap
24.6M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,108
P/E Ratio
-
Beta
-
1-Year Change
-12.04%
Shares Outstanding
13,534,389
Next Earnings Date
-
What is your sentiment on Rxi Pharmaceuticals Corp?
or
Market is currently closed. Voting is open during market hours.

Rxi Pharmaceuticals Corp News

Rxi Pharmaceuticals Corp Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellNeutralStrong BuySell
Technical IndicatorsSellSellNeutralStrong BuySell
SummarySellSellNeutralStrong BuySell

Rxi Pharmaceuticals Corp Company Profile

Rxi Pharmaceuticals Corp Company Profile

Employees
10

Phio Pharmaceuticals Corp, formerly RXi Pharmaceuticals Corporation, is a biotechnology company. The Company is focused on developing immuno-oncology therapeutics based on its self-delivering ribonucleic acid interface (RNAi) (sd-rxRNA) therapeutic platform. The Company’s focuses on developing sd-rxRNA therapeutic compounds to be used in the context of adoptive cell transfer by targeting checkpoints or other gene targets, or to be used in immunotherapy following intratumoral injection. The Company’s pipeline include RXI-762 and RXI-804. Its sd-rxRNA compounds are designed to down-regulate the expression of a specific gene that may be over-expressed in a disease condition. The Company is developing RXI-762 for the treatment of Melanoma, Ovarian cancer and other indications. RXI-804 is an sd-rxRNA compound that is designed to suppress the expression of immune checkpoint protein, TIGIT.

Read More
  • PHIO Sept 16-21 ESMO Abstract Title says it all -> "persistent immunity" & "complete resolution of tumors" (eg 100% tumor elimination & lasting cancer immunity) can't get any better than that. Truly the Market hates PHIO/RXII because of the 'cloud' of 4 R/S 1,000:1 Otherwise PHIO PPS would've exploded. Only other explanation is that the investing public can't read or comprehend the impact of a cure for cancer.
    0
    • Nice move so far today
      0
      • THIS IS GOING TO 6
        0
        • 123 boom
          0
          • Target 10$
            0
            • $5.75
              0
              • Why such thebig fump
                0
            • going up
              0
              • is this going to keep going up or dip
                0
                • did they already have earnings call?
                  0
                  • will up
                    1
                    • you believe so Ammar
                      1
                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.